A simple and robust strategy developed by KAUST scientists could help to improve the safety and accuracy of CRISPR gene editing, a tool that is already approved for clinical use for the treatment of inherited blood disorders.
New strategy suppresses unwanted deletion events to make genome editing safer and more precise
Posted in bioengineering, biotech/medical